Data / Form D filings / Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc.: Form D filings
Avalo Therapeutics, Inc., a biotechnology company in Rockville, MD, filed 6 Form D notices with the SEC between 2012 and 2024. The latest, on April 9, 2024, reports $130.6 million sold of a $200 million offering to 25 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 540 GAITHER ROAD, SUITE 400, Rockville, MD, 20850
- Phone
- (410) 522-8707
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1534120
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | New notice | $199,976,986 | $130,601,986 | $69,375,000 | 25 | Mar 27, 2024 | sec.gov |
| May 8, 2017 | New notice | $5,000,000 | $5,000,000 | 1 | Apr 27, 2017 | sec.gov | |
| Sep 16, 2016 | New notice | $15,000,000 | $1,000,000 | $14,000,000 | 1 | Sep 8, 2016 | sec.gov |
| Jul 21, 2014 | New notice | $33,259,016 | $16,259,016 | $17,000,000 | 13 | Jul 11, 2014 | sec.gov |
| Sep 6, 2013 | New notice | $10,000,000 | $6,805,883 | $3,194,117 | 146 | Aug 23, 2013 | sec.gov |
| Apr 4, 2012 | New notice | $22,500,000 | $22,137,301 | $362,699 | 156 | Mar 23, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| June Almenoff, M.D., Ph.D. | Director | |
| Mitchell Chan | Director | |
| Jonathan Goldman, M.D. | Director | |
| Aaron Kantoff | Director | |
| Gilla Kaplan, Ph.D. | Director | |
| Magnus Persson, M.D., Ph.D. | Director | |
| Samantha Truex | Director | |
| Christopher Sullivan | Executive Officer | |
| Garry Neil, M.D. | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Apr 8, 2024 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Avalo Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.